Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
<p dir="ltr">Lactate dehydrogenase C (LDHC) is an archetypical cancer testis antigen with limited expression in adult tissues and re-expression in tumors. This restricted expression pattern together with the important role of LDHC in cancer metabolism renders LDHC a potential target...
Saved in:
| Main Author: | Remy Thomas (702843) (author) |
|---|---|
| Other Authors: | Hibah Shaath (5599658) (author), Adviti Naik (673163) (author), Salman M. Toor (8854751) (author), Eyad Elkord (5396390) (author), Julie Decock (44558) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
by: A. Naik (7783220)
Published: (2023) -
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
by: Adviti Naik (673163)
Published: (2021) -
Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer
by: Adviti Naik (673163)
Published: (2025) -
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
by: Remy Thomas (702843)
Published: (2018) -
Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
by: Ghaneya Al-Khadairi (14153274)
Published: (2019)